Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model

被引:105
作者
Ludewig, B [1 ]
Freigang, S
Jäggi, M
Kurrer, MO
Pei, YC
Vlk, L
Odermatt, B
Zinkernagel, RM
Hengartner, H
机构
[1] Univ Zurich, Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Univ Zurich Hosp, Inst Clin Pathol, Dept Pathol, CH-8091 Zurich, Switzerland
[3] Univ Zurich, Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland
关键词
D O I
10.1073/pnas.220427097
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Arterial inflammatory responses are thought to be a significant component of atherosclerotic disease. We describe here, using a transgenic approach, the mutual perpetuation of immune-mediated arterial inflammation and cholesterol-induced atherosclerosis. Mice expressing the bacterial transgene beta -galactosidase exclusively in cardiomyocytes and in smooth muscle cells in lung arteries and the aorta (SM-LacZ), and hypercholesterolemic apolipoprotein E-deficient SM-LacZ mice (SM-LacZ/apoE(-/-)) developed myocarditis and arteritis after immunization with dendritic cells presenting a beta -galactosidase-derived immunogenic peptide. Hypercholesterolemia amplified acute arteritis and perpetuated chronic arterial inflammation in SM-LacZ/apoE(-/-) mice, but had no major impact on acute myocarditis or the subsequent development of dilated cardiomyopathy. Conversely, arteritis significantly accelerated cholesterol-induced atherosclerosis. Taken together, these data demonstrate that the linkage of immune-mediated arteritis and hypercholesterolemia favors initiation and maintenance of atherosclerotic lesion formation. Therapeutic strategies to prevent or disrupt such self-perpetuating vicious circles may be crucial for the successful treatment of atherosclerosis.
引用
收藏
页码:12752 / 12757
页数:6
相关论文
共 33 条
[1]  
ADAM E, 1987, LANCET, V2, P291
[2]   Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities [J].
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) :1360-1369
[3]  
Chiu B, 1997, CIRCULATION, V96, P2144
[4]   THERAPY WITH MONOCLONAL-ANTIBODIES BY ELIMINATION OF T-CELL SUBSETS INVIVO [J].
COBBOLD, SP ;
JAYASURIYA, A ;
NASH, A ;
PROSPERO, TD ;
WALDMANN, H .
NATURE, 1984, 312 (5994) :548-551
[5]   T and B lymphocytes play a minor sole in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse [J].
Dansky, HM ;
Charlton, SA ;
Harper, MM ;
Smith, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4642-4646
[6]   INDUCTION AND THERAPY OF AUTOIMMUNE DIABETES IN THE NON-OBESE DIABETIC (NOD/LT) MOUSE BY A 65-KDA HEAT-SHOCK PROTEIN [J].
ELIAS, D ;
MARKOVITS, D ;
RESHEF, T ;
VANDERZEE, R ;
COHEN, IR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1576-1580
[7]   VIRUS-INDUCED ATHEROSCLEROSIS [J].
FABRICANT, CG ;
FABRICANT, J ;
LITRENTA, MM ;
MINICK, CR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (01) :335-340
[8]   Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65 [J].
George, J ;
Shoenfeld, Y ;
Afek, A ;
Gilburd, B ;
Keren, P ;
Shaish, A ;
Kopolovic, J ;
Wick, G ;
Harats, D .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :505-510
[9]  
HANSSON GK, 1989, AM J PATHOL, V135, P169
[10]  
HENDRIX MGR, 1990, AM J PATHOL, V136, P23